Prescribing Information
Arman Pejmanfar: System Owner
Allison McInerney: Business Owner
Supplier/Vendor host: DXC
Site Manager: Deana Lysy
United States Digital Labeling
Source URL for Web development
Posting Effective Date
(Internet/public domain posting date)
(Internet/public domain posting date)
Exception / Notes / Comments
https://www.pi.amgen.com/united_states/actimunne/actimunne_fpi_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/actimunne/actimunne_IFU_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/aimovig/Aimovig_pi_hcp_english.pdf
08/15/2024
PFS IFU is not marketed in the US at this time
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ifu_hcp_pt_english.pdf
08/15/2024
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ifu_140_english.pdf
08/15/2024
https://www.pi.amgen.com/united_states/aimovig/Aimovig_pi_hcp_spanish.pdf
04/26/2024
PFS IFU is not marketed in the US at this time
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ifu_hcp_pt_spanish.pdf
04/26/2024
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ifu_140_spanish.pdf
04/26/2024
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ppi_pt_spanish.pdf
04/26/2024
https://www.pi.amgen.com/united_states/aimovig70/Aimovig_rg_english.pdf
08/15/2024
https://www.pi.amgen.com/united_states/aimovig140/Aimovig_rg_english.pdf
08/15/2024
https://www.pi.amgen.com/united_states/aimovig/Aimovig_eifu_140_english.pdf
04/29/2022
https://www.pi.amgen.com/united_states/amjevita/AMJEVITA_pi_hcp_english.pdf
08/29/2024
https://www.pi.amgen.com/united_states/amjevita/amjevita_pfsifu.pdf
08/01/2022
https://www.pi.amgen.com/united_states/amjevita/amjevita_scifu.pdf
08/15/2023
https://www.pi.amgen.com/united_states/aranesp/ckd/aranesp_pi_hcp_english.pdf
05/02/2024
https://www.pi.amgen.com/united_states/aranesp/ckd/aranesp_mg_hcp_english.pdf
05/02/2024
https://www.pi.amgen.com/united_states/aranesp/ckd/aranesp_piu_pt_vial_english.pdf
05/31/2012
https://www.pi.amgen.com/united_states/aranesp/ckd/aranesp_piu_pt_singleject_english.pdf
04/27/2016
https://www.pi.amgen.com/united_states/avsola/avsola_pi_english.pdf
09/13/2021
https://www.pi.amgen.com/united_states/BKEMV/BKEMV_fpi_hcp_english.pdf
10/28/2024
NOTE: This is not on offer for sale. FDA Approval Date: May 28, 2024. BKEMV is not commercially available and will not be available until a later date.
https://www.pi.amgen.com/united_states/BKEMV/BKEMV_mg.pdf
10/28/2024
NOTE: This is not on offer for sale. FDA Approval Date: May 28, 2024. BKEMV is not commercially available and will not be available until a later date.
https://www.pi.amgen.com/united_states/blincyto/blincyto_pi_hcp_english.pdf
07/09/2024
https://www.pi.amgen.com/united_states/blincyto/blincyto_mg_hcp_english.pdf
06/14/2024
https://www.pi.amgen.com/united_states/blincyto/blincyto_consumer_isi.pdf
04/13/2022
https://www.pi.amgen.com/united_states/buphenyl/buphenyl_fpi_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/corlanor/corlanor_pi.pdf
08/12/2021
https://www.pi.amgen.com/united_states/corlanor/corlanor_pi_hcp.pdf
08/12/2021
https://www.pi.amgen.com/united_states/DUEXIS/duexis_fpi_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/DUEXIS/duexis_isi_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/DUEXIS/duexis_mg_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/epogen/epogen_pi_hcp_english.pdf
05/02/2024
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_pi.pdf
09/17/2024
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_pi_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_mg.pdf
09/17/2024
https://www.pi.amgen.com/united_states/enbrel/derm/mg_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_piu.pdf
07/25/2024
https://www.pi.amgen.com/united_states/enbrel/derm/Combined_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_scifu.pdf
07/25/2024
https://www.pi.amgen.com/united_states/enbrel/derm/SCI_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_sdvifu.pdf
06/21/2022
https://www.pi.amgen.com/united_states/enbrel/derm/SDV_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_PFSIFU.pdf
07/31/2023
https://www.pi.amgen.com/united_states/enbrel/derm/PFS_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_MUVIFU.pdf
11/08/2019
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_ATIFU.pdf
07/31/2023
https://www.pi.amgen.com/united_states/enbrel/derm/AT_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_user_manual_for_auto_touch_connect.pdf
07/25/2024
https://www.pi.amgen.com/united_states/evenity/evenity_pi.pdf
05/01/2020
https://www.pi.amgen.com/united_states/evenity/evenity_pi_hcp_english.pdf
05/01/2020
https://www.pi.amgen.com/united_states/Imdelltra/imdelltra_fpi.pdf
05/16/2024
https://www.pi.amgen.com/united_states/Imdelltra/imdelltra_mg.pdf
05/16/2024
https://www.pi.amgen.com/united_states/Imdelltra/imdelltra_pi.pdf
05/16/2024
https://www.pi.amgen.com/united_states/imlygic/imlygic_pi.pdf
02/10/2023
https://www.pi.amgen.com/united_states/kanjinti/kanjinti_pi.pdf
10/17/2022
https://www.pi.amgen.com/united_states/Krystexxa/Krystexxa_fpi_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/Krystexxa/Krystexxa_mg_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/kyprolis/kyprolis_pi.pdf
07/01/2022
https://www.pi.amgen.com/united_states/lumakras/lumakras_pi_hcp_english.pdf
10/01/2024
https://www.pi.amgen.com/united_states/lumakras/lumakras_ppi_pt_english.pdf
01/20/2023
https://www.pi.amgen.com/united_states/mvasi/MVASI_pi_hcp_english.pdf
02/20/2023
https://www.pi.amgen.com/united_states/neulasta/neulasta_pi_hcp_english.pdf
12/20/2023
https://www.pi.amgen.com/united_states/neulasta/neulasta_ppi_pt_english.pdf
01/14/2021
https://www.pi.amgen.com/united_states/neulasta/neulasta_ifu_hcp_pt_english.pdf
12/20/2023
https://www.pi.amgen.com/united_states/neulasta/neulasta_hcp_ifu_obi.pdf
03/05/2021
https://www.pi.amgen.com/united_states/neulasta/neulasta_patient_ifu_obi.pdf
01/04/2021
https://www.pi.amgen.com/united_states/neupogen/neupogen_pi_hcp_english.pdf
04/19/2023
https://www.pi.amgen.com/united_states/neupogen/neupogen_ppi_pt_english.pdf
01/14/2021
https://www.pi.amgen.com/united_states/neupogen/neupogen_vial_ifu.pdf
06/29/2016
https://www.pi.amgen.com/united_states/nplate/nplate_pi_hcp_english.pdf
02/15/2022
https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf
04/26/2024
https://www.pi.amgen.com/united_states/otezla/otezla_pi_spanish.pdf
10/09/2024
https://www.pi.amgen.com/united_states/pavblu/pavblu_fpi_english.pdf
09/24/2024
https://www.pi.amgen.com/united_states/PENNSAID/pennsaid_fpi_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/PENNSAID/pennsaid_isi_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/PENNSAID/pennsaid_mg_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/prolia/prolia_pi.pdf
03/06/2024
https://www.pi.amgen.com/united_states/prolia/prolia_isi_combined.pdf
02/14/2024
Not labeling; exception for ISI to be digitally linked for REMS website ONLY. January 2024 label effective date
https://www.pi.amgen.com/united_states/Procysbi/Procysbi_fpi_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/Procysbi/Procysbi_ppi_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/Procysbi/Procysbi_ifu_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/Ravicti/ravicti_fpi_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/Ravicti/ravicti_mg_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/Rayos/rayos_fpi_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/Rayos/rayos_isi_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english.pdf
08/23/2024
PFS IFU is not marketed in the US at this time.
https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_spanish.pdf
01/09/2023
PFS is not Marketed at this time and was not translated for digital dissemination
https://www.pi.amgen.com/united_states/repatha/repatha_ppi_pt_spanish.pdf
01/09/2023
https://www.pi.amgen.com/united_states/repatha/repatha_ifu_hcp_pt_english.pdf
08/23/2024
https://www.pi.amgen.com/united_states/repatha/repatha_AI-IFU_spanish.pdf
01/09/2023
https://www.pi.amgen.com/united_states/repatha/repatha_pfs_ifu_hcp_pt_english.pdf
09/27/2021
PFS not marketed at this time
https://www.pi.amgen.com/united_states/repatha/repatha_obi_ifu_hcp_pt_english.pdf
09/27/2021
https://www.pi.amgen.com/united_states/repatha/repatha_OBI-IFU_spanish.pdf
01/09/2023
https://www.pi.amgen.com/united_states/repatha/repatha_rg_english.pdf
08/17/2022
https://www.pi.amgen.com/united_states/repatha/repatha_rg_spanish.pdf
01/09/2023
https://www.pi.amgen.com/united_states/riabni/riabni_pi_english.pdf
02/20/2024
https://www.pi.amgen.com/united_states/sensipar/sensipar_pi_hcp_english.pdf
12/06/2019
https://www.pi.amgen.com/united_states/Tavneos/tavneos_fpi_english.pdf
06/05/2024
https://www.pi.amgen.com/united_states/Tavneos/tanveos_mg_english.pdf
12/13/2023
https://www.pi.amgen.com/united_states/tepezza/tepezza_fpi_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/uplizna/uplizna_fpi_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/uplizna/uplizna_mg_english.pdf
10/21/2024
https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf
05/26/2023
URL redirects to AZPI Central labeling
https://www.pi.amgen.com/united_states/tezspire/tezspire_ppi_pt_english.pdf
02/02/2023
URL redirects to AZPI Central labeling
https://www.pi.amgen.com/united_states/tezspire/tezspire_ifu_english.pdf
02/02/2023
URL redirects to AZPI Central labeling
https://www.pi.amgen.com/united_states/tezspire/tezspire_FPI_Spanish.pdf
03/03/2023
URL redirects to AZPI Central Labeling
https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_spanish.pdf
01/25/2023
https://www.pi.amgen.com/united_states/tezspire/tezspire_ppi_pt_spanish.pdf
01/25/2023
https://www.pi.amgen.com/united_states/tezspire/tezspire_ifu_spanish.pdf
01/25/2023
https://www.pi.amgen.com/united_states/vectibix/vectibix_pi.pdf
08/30/2021
https://www.pi.amgen.com/united_states/VIMOVO/vimovo_fpi_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/VIMOVO/vimovo_isi_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/VIMOVO/vimovo_mg_english.pdf
07/15/2024
https://www.pi.amgen.com/united_states/WEZLANA/Wezlana_fpi_hcp_english.pdf
07/10/2024
NOTE: This is not an offer for sale. FDA Approval Date: October 31, 2023. WEZLANA™
is currently not available commercially and will be commercially available in the United States no later than January 1, 2025.
https://www.pi.amgen.com/united_states/WEZLANA/wezlana_mg.pdf
07/10/2024
NOTE: This is not an offer for sale. FDA Approval Date: October 31, 2023. WEZLANA™
is currently not available commercially and will be commercially available in the United States no later than January 1, 2025.
https://www.pi.amgen.com/united_states/WEZLANA/wezlana_pfsifu.pdf
07/10/2024
NOTE: This is not an offer for sale. FDA Approval Date: October 31, 2023. WEZLANA™
is currently not available commercially and will be commercially available in the United States no later than January 1, 2025.
https://www.pi.amgen.com/united_states/WEZLANA/wezlana_sdvifu.pdf
07/10/2024
NOTE: This is not an offer for sale. FDA Approval Date: October 31, 2023. WEZLANA™
is currently not available commercially and will be commercially available in the United States no later than January 1, 2025.
https://www.pi.amgen.com/united_states/xgeva/xgeva_pi.pdf
06/10/2020